Market Research Life Sciences Market Research Pharmaceuticals Market Research Drug Discovery Market Research

Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 105 Pages Triton Market Research August, 2022 TRTN17344024
Best Price Guarantee
Price from $1,500
Length 105 Pages
Publisher Triton Market Research
Published Date August, 2022
SKU TRTN17344024

Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028

MARKET OUTLOOK

Triton Market Research has put forth that the Alzheimer’s disease therapeutics and diagnostics market in Latin America is likely to grow with a 6.19% of CAGR over the forecast years from 2022-2028. Mexico, Brazil, and Rest of Latin America are analyzed in the market in this region.

In 2019, a major international initiative for Alzheimer’s disease led by the School of Medicine at Washington University opened five new sites in the region, including Brazil, Argentina, Mexico, and Colombia. The objective was to conduct research & development activities on Alzheimer’s disease.

Further, there are a number of academic research groups and non-governmental organizations (NGOs) engaged in Alzheimer’s disease-related research. The Brazilian Association of Alzheimer’s (ABRAz), which is a leading national NGO, offers support to families of patients affected by dementia. The nation has also managed to gain the attention of private healthcare insurance-providing companies.

Besides, a number of workshops and programs are being held across the country for understanding Alzheimer’s disease management. For instance, a UK-Brazil dementia workshop, held in 2019, revealed that the nation faces a major challenge of underdiagnosis of Alzheimer’s disease and dementia. This highlights the immense need for awareness, diagnosis, and treatment of Alzheimer’s disease in the country, and, in turn, is expected to drive the market growth.

COMPETITIVE OUTLOOK

Merck and Co, Lupin Limited, F. Hoffmann-La Roche AG, Pfizer Inc, Zydus Cadila, Johnson and Johnson, Sun Pharmaceuticals Industries Ltd, Novartis AG, and Baxter International Inc are some of the prominent names operating in the Alzheimer’s disease therapeutics and diagnostics market.


1. Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market – Summary
2. Industry Outlook
2.1. Timeline Of Alzheimer’s Disease Therapeutics And Diagnostics Market
2.2. Phases And Sternness Of Alzheimer’s Disease
2.3. Key Insights
2.3.1. Usage Of Computed Tomography For The Diagnosis Of Alzheimer’s Disease
2.3.2. R&D Investments In Biomarkers For Early Detection Of Dementia
2.3.3. Demand For Personalized Medicines
2.4. Impact Of Covid-19 On The Alzheimer’s Disease Therapeutics And Diagnostics Market
2.5. Porter’s Five Forces Analysis
2.6. Market Attractiveness Matrix
2.7. Vendor Scorecard
2.8. Industry Components
2.8.1. Research & Development (R & D)
2.8.2. Raw Materials
2.8.3. Manufacturing
2.8.4. Distributors/Wholesalers/Retailers
2.8.5. End-user
2.9. Key Impact Analysis
2.9.1. Effectiveness
2.9.2. Price
2.9.3. Safety
2.10. Key Market Strategies
2.10.1. Acquisitions
2.10.2. Product Launches
2.10.3. Contracts & Agreements
2.10.4. Investments & Expansions
2.11. Market Drivers
2.11.1. Prevalence Of Alzheimer’s Disease
2.11.2. Rise In The Elderly Population
2.12. Market Challenges
2.12.1. Failure Of Late-stage Drugs
2.12.2. Stringent Government Regulations
2.13. Market Opportunities
2.13.1. Emergence Of New Diagnostic Technologies
2.13.2. Growing Number Of Pipeline Drugs
3. Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market – By Therapeutics
3.1. By Drug Type
3.1.1. Marketed Drugs
3.1.2. Pipeline Drugs
3.2. By Disease Stage
3.2.1. Late Stage: Severe Ad
3.2.2. Early/Middle Stage: Mild To Moderate Ad
3.2.3. Prodromal Stage
3.3. By Generic & Branded
3.3.1. Branded
3.3.2. Generic
4. Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market – By Diagnostics
4.1. Lumbar Puncture Test
4.2. Positron Emission Tomography
4.3. Electroencephalography
4.4. Magnetic Resonance Imaging
4.5. Computed Tomography
4.6. Blood Test
4.7. Other Diagnostics
5. Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market – Country Outlook
5.1. Brazil
5.2. Mexico
5.3. Rest Of Latin America
6. Competitive Landscape
6.1. Baxter International Inc
6.2. F. Hoffmann-la Roche Ag
6.3. Allergan Plc (Acquired By Abbvie)
6.4. Novartis Ag
6.5. Pfizer Inc
6.6. Siemens Healthineers Ag
6.7. Amarantus Bioscience Holdings Inc
6.8. Eisai Co Ltd
6.9. Eli Lilly & Company
6.10. Lupin Limited
6.11. Merck And Co
6.12. Biogen Inc
6.13. Cognoptix Inc
6.14. Ge Healthcare
6.15. Johnson And Johnson
6.16. Sun Pharmaceuticals Industries Ltd
6.17. Teva Pharmaceutical Industries Ltd
6.18. Zydus Cadila
7. Methodology & Scope
7.1. Research Scope
7.2. Sources Of Data
7.3. Research Methodology
Table List
Table 1: Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market, Country Outlook, 2022-2028 (In $ Million)
Table 2: Market Attractiveness Matrix
Table 3: Vendor Scorecard
Table 4: Key Strategic Developments
Table 5: Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market, By Therapeutics, 2022-2028 (In $ Million)
Table 6: Latin America Alzheimer’s Disease Therapeutics Market, By Drug Type, 2022-2028 (In $ Million)
Table 7: Latin America Alzheimer’s Disease Therapeutics Market, By Disease Stage, 2022-2028 (In $ Million)
Table 8: Latin America Alzheimer’s Disease Therapeutics Market, By Generic & Branded, 2022-2028 (In $ Million)
Table 9: Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market, By Diagnostics, 2022-2028 (In $ Million)
Table 10: Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market, Country Outlook, 2022-2028 (In $ Million)
Figure List
Figure 1: Porter’s Five Forces Analysis
Figure 2: Key Impact Analysis
Figure 3: Timeline Of Alzheimer’s Disease Therapeutics And Diagnostics
Figure 4: Industry Components
Figure 5: Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market, By Therapeutics, 2021 & 2028 (In %)
Figure 6: Latin America Alzheimer’s Disease Therapeutics Market, By Drug Type, 2021 & 2028 (In %)
Figure 7: Latin America Alzheimer’s Disease Therapeutics Market, By Marketed Drugs, 2022-2028 (In $ Million)
Figure 8: Latin America Alzheimer’s Disease Therapeutics Market, By Pipeline Drugs, 2022-2028 (In $ Million)
Figure 9: Latin America Alzheimer’s Disease Therapeutics Market, By Disease Stage, 2021 & 2028 (In %)
Figure 10: Latin America Alzheimer’s Disease Therapeutics Market, By Late Stage: Severe Ad, 2022-2028 (In $ Million)
Figure 11: Latin America Alzheimer’s Disease Therapeutics Market, By Early/Middle Stage: Mild To Moderate Ad, 2022-2028 (In $ Million)
Figure 12: Latin America Alzheimer’s Disease Therapeutics Market, By Prodromal Stage, 2022-2028 (In $ Million)
Figure 13: Latin America Alzheimer’s Disease Therapeutics Market, By Generic & Branded, 2021 & 2028 (In %)
Figure 14: Latin America Alzheimer’s Disease Therapeutics Market, By Branded, 2022-2028 (In $ Million)
Figure 15: Latin America Alzheimer’s Disease Therapeutics Market, By Generic, 2022-2028 (In $ Million)
Figure 16: Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market, By Diagnostics, 2021 & 2028 (In %)
Figure 17: Latin America Alzheimer’s Disease Diagnostics Market, By Lumbar Puncture Test, 2022-2028 (In $ Million)
Figure 18: Latin America Alzheimer’s Disease Diagnostics Market, By Positron Emission Tomography, 2022-2028 (In $ Million)
Figure 19: Latin America Alzheimer’s Disease Diagnostics Market, By Electroencephalography, 2022-2028 (In $ Million)
Figure 20: Latin America Alzheimer’s Disease Diagnostics Market, By Magnetic Resonance Imaging, 2022-2028 (In $ Million)
Figure 21: Latin America Alzheimer’s Disease Diagnostics Market, By Computed Tomography, 2022-2028 (In $ Million)
Figure 22: Latin America Alzheimer’s Disease Diagnostics Market, By Blood Test, 2022-2028 (In $ Million)
Figure 23: Latin America Alzheimer’s Disease Diagnostics Market, By Other Diagnostics, 2022-2028 (In $ Million)
Figure 24: Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market, Country Outlook, 2021 & 2028 (In %)
Figure 25: Brazil Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028 (In $ Million)
Figure 26: Mexico Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028 (In $ Million)
Figure 27: Rest Of Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028 (In $ Million)

$1,500
$2,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings